Friday Dec 21, 2018

Biotech strategy and nanomedicine: the pharmaphorum podcast

For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.

Comment (0)

No comments yet. Be the first to say something!

© 2022 Pharmaphorum

Podcast Powered By Podbean

Version: 20241125